NO166494C - Fremgangsmaate for fremstilling av human lymfoblastoid interferon. - Google Patents

Fremgangsmaate for fremstilling av human lymfoblastoid interferon.

Info

Publication number
NO166494C
NO166494C NO823314A NO823314A NO166494C NO 166494 C NO166494 C NO 166494C NO 823314 A NO823314 A NO 823314A NO 823314 A NO823314 A NO 823314A NO 166494 C NO166494 C NO 166494C
Authority
NO
Norway
Prior art keywords
procedure
preparation
human lymphoblastoid
lymphoblastoid interferon
interferon
Prior art date
Application number
NO823314A
Other languages
English (en)
Other versions
NO823314L (no
NO166494B (no
Inventor
Francois Meyer
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27261323&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO166494(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO823314L publication Critical patent/NO823314L/no
Publication of NO166494B publication Critical patent/NO166494B/no
Publication of NO166494C publication Critical patent/NO166494C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO823314A 1981-10-03 1982-10-01 Fremgangsmaate for fremstilling av human lymfoblastoid interferon. NO166494C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8129937 1981-10-03
GB8208988 1982-03-26
GB08224871A GB2108510B (en) 1981-10-03 1982-09-01 Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof

Publications (3)

Publication Number Publication Date
NO823314L NO823314L (no) 1983-04-05
NO166494B NO166494B (no) 1991-04-22
NO166494C true NO166494C (no) 1991-08-07

Family

ID=27261323

Family Applications (1)

Application Number Title Priority Date Filing Date
NO823314A NO166494C (no) 1981-10-03 1982-10-01 Fremgangsmaate for fremstilling av human lymfoblastoid interferon.

Country Status (19)

Country Link
US (1) US5089400A (no)
EP (1) EP0076489B1 (no)
JP (2) JPH06104066B2 (no)
KR (1) KR920007665B1 (no)
AU (1) AU561104B2 (no)
DD (1) DD204266A5 (no)
DE (1) DE3280174D1 (no)
DK (1) DK170714B1 (no)
ES (2) ES516154A0 (no)
FI (1) FI80719C (no)
GB (1) GB2108510B (no)
GR (1) GR76992B (no)
HU (1) HU197047B (no)
IE (1) IE54051B1 (no)
IL (1) IL66920A0 (no)
NO (1) NO166494C (no)
NZ (1) NZ202058A (no)
PH (2) PH21524A (no)
PT (1) PT75643B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
DE3220116A1 (de) 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
CA1271717A (en) * 1982-10-11 1990-07-17 National Biological Standards Board Polypeptides useful in vaccination against enteroviruses
IE56509B1 (en) * 1982-11-04 1991-08-28 Univ California Methods for oncogenic detection
JPS60118196A (ja) * 1983-11-30 1985-06-25 Takeda Chem Ind Ltd インタ−フェロンの製造法
JPS6156199A (ja) * 1984-08-27 1986-03-20 Shionogi & Co Ltd 新規ヒトインタ−フエロンα類
DE3685044D1 (de) * 1985-02-01 1992-06-04 Ici Plc Analoge interferon-polypeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
GB8508685D0 (en) * 1985-04-03 1985-05-09 Minor P D Peptides
ATE81675T1 (de) * 1985-04-30 1992-11-15 Takeda Chemical Industries Ltd Produktion eines proteins.
EP0205404B1 (en) * 1985-06-11 1992-07-15 Ciba-Geigy Ag Hybrid interferons
ATE125304T1 (de) 1986-04-15 1995-08-15 Ciba Geigy Ag Monoklonale antikörper gegen interferon- induziertes humanes protein in gereignigter form, und diese antikörper enthaltende testsätze.
TW218846B (no) * 1992-04-07 1994-01-11 Ciba Geigy
US5834202A (en) * 1992-08-04 1998-11-10 Replicon, Inc. Methods for the isothermal amplification of nucleic acid molecules
US5733733A (en) * 1992-08-04 1998-03-31 Replicon, Inc. Methods for the isothermal amplification of nucleic acid molecules
WO1994003624A1 (en) * 1992-08-04 1994-02-17 Auerbach Jeffrey I Methods for the isothermal amplification of nucleic acid molecules
US6261808B1 (en) 1992-08-04 2001-07-17 Replicon, Inc. Amplification of nucleic acid molecules via circular replicons
US20020102236A1 (en) * 1994-12-08 2002-08-01 Taylor Peter William Liposomal interferon hybrid compositions
DK0801682T3 (da) 1995-02-09 2002-02-18 Aventis Pharma Gmbh Fremgangsmåde til fremstilling af proteiner
US6087102A (en) * 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
US6685933B1 (en) 1998-07-28 2004-02-03 The United States Of America As Represented By The Department Of Health And Human Services Interferon α hybrids
DE19919149A1 (de) * 1999-04-27 2000-11-16 Wieser Raimund J Von Interferon alpha-2 abgeleitete Peptid-Homodimere und Peptid-Heterodimere
WO2002036627A2 (en) * 2000-11-03 2002-05-10 Pbl Biomedical Laboratories Interferons, uses and compositions related thereto
WO2002088161A1 (en) * 2001-05-02 2002-11-07 Pepgen Corporation Method for expression of human interferon alpha 1 in pichia pa storis
FR2825716B1 (fr) 2001-06-11 2004-09-24 Genodyssee Nouveaux polynucleotides et polypeptides de l'ifn alpha 7
EA013263B1 (ru) * 2004-12-20 2010-04-30 Кадила Хелзкэр Лимитед Способ получения интерферона-бета
US20190071589A1 (en) 2016-11-21 2019-03-07 Nitto Denko Corporation Pressure-sensitive adhesive sheet
US20190077999A1 (en) 2016-11-21 2019-03-14 Nitto Denko Corporation Pressure-sensitive adhesive sheet

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA796175B (en) * 1978-11-24 1980-11-26 Hoffmann La Roche Purified proteins and process therefor
AU538665B2 (en) * 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
NZ195980A (en) * 1980-01-08 1984-10-19 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing leukocyte interferon-like polypeptides;pharmaceutical and veterinary compositions
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
JP2687995B2 (ja) * 1980-04-03 1997-12-08 バイオゲン インコーポレイテッド Ｄｎａ配列、組替えｄｎａ分子およびヒト繊維芽細胞インターフェロン様ポリペプチドの製造方法
EP0042246B1 (en) * 1980-06-12 1987-03-18 The Cancer Institute Of Japanese Foundation For Cancer Research Plasmid
ES8302778A1 (es) * 1980-11-10 1983-02-01 Genentech Inc Un procedimiento para producir un polipeptido antiviral.
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof

Also Published As

Publication number Publication date
PT75643A (en) 1982-11-01
EP0076489B1 (de) 1990-05-16
FI823356A0 (fi) 1982-10-01
NZ202058A (en) 1986-05-09
IE822385L (en) 1983-04-30
FI80719B (fi) 1990-03-30
JPS5890596A (ja) 1983-05-30
GB2108510B (en) 1984-12-12
US5089400A (en) 1992-02-18
GR76992B (no) 1984-09-04
AU561104B2 (en) 1987-04-30
KR840002031A (ko) 1984-06-11
GB2108510A (en) 1983-05-18
PH23119A (en) 1989-05-05
EP0076489A3 (en) 1984-03-28
NO823314L (no) 1983-04-05
JPH07173195A (ja) 1995-07-11
AU8895882A (en) 1983-04-14
IL66920A0 (en) 1982-12-31
EP0076489A2 (de) 1983-04-13
PT75643B (en) 1986-11-13
NO166494B (no) 1991-04-22
FI823356L (fi) 1983-04-04
DD204266A5 (de) 1983-11-23
IE54051B1 (en) 1989-05-24
KR920007665B1 (ko) 1992-09-14
DK437382A (da) 1983-04-04
ES8504936A1 (es) 1985-04-16
ES516154A0 (es) 1985-04-16
DE3280174D1 (de) 1990-06-21
PH21524A (en) 1987-11-16
DK170714B1 (da) 1995-12-18
ES8601237A1 (es) 1985-11-01
FI80719C (fi) 1990-07-10
JPH06104066B2 (ja) 1994-12-21
HU197047B (en) 1989-02-28
ES528141A0 (es) 1985-11-01
JP2612149B2 (ja) 1997-05-21

Similar Documents

Publication Publication Date Title
NO166494C (no) Fremgangsmaate for fremstilling av human lymfoblastoid interferon.
NO154905C (no) Fremgangsmaate for fremstilling av preparater for behandling av melanomer.
NO821137L (no) Fremgangsmaate for fremstilling av tertiaere alkyletere
NO821087L (no) Fremgangsmaate for fremstilling av cyklobutan-derivater.
RO86213A (ro) Procedeu pentru prepararea izobutenei
NO154492C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme forbindelser.
IT8124141A0 (it) Procedimento per lapreparazione di 4'-deossi-daunorubicina 4'-deossi-doxorubicina.
ES513672A0 (es) "procedimiento para la preparacion de derivados de penem".
ES511220A0 (es) "procedimiento de preparacion de nuevos derivados 4-aminoetoxi-5-isopropil-2-metil".
NO160335C (no) Fremgangsmaate for fremstilling av roerkokiller.
IT8124574A0 (it) Procedimento per la preparazione ela separazione di metil ter-butiletere.
IT1157058B (it) Procedimento per la preparazione di acril e metaacrilamidi n.sostituite
ES510963A0 (es) Procedimiento de preparacion de alcoxiaminohidridosilanos.
ES509504A0 (es) "procedimiento de preparacion de globulina antilinfocitaria t".
NO159268C (no) Fremgangsmaate for fremstilling av 3-pikolin.
ES507180A0 (es) Procedimiento de preparacion de amino alcosi furanos o tio- fenos.
NO863769D0 (no) Fremgangsmaate for fremstilling av 4-hydroksy-2-oksopyrrolin-1-yl-acetamid.
IT8224818A0 (it) Procedimento per la preparazione del7-metil-3-metilen-7-otten-1-il-propionato.
NO864087D0 (no) Fremgangsmaate for fremstilling av aroylthiazoloner.
NO822215L (no) Fremgangsmaate for fremstilling av kreftcellebekjempende lymphocyter.
NO821874L (no) Fremgangsmaate for fremstilling av fenoletere.
IT8224536A0 (it) Procedimento di preparazione di mononitroclorobenzene.
ES516534A0 (es) "procedimiento de preparacion de 2-isopropilamino-pirimidina-n-oxido".
ES511281A0 (es) "procedimiento de preparacion de fusafungina".
IT1155455B (it) Procedimento per la preparazione di imidazolilvinileteri